Intravascular Lithotripsy (IVL) for Coronary Calcium Modification, Data Review

Faculty

David E. Kandzari, MD, FSCAI

Sunil V. Rao, MD, FSCAI

Content

00:48. When do you suspect calcification?
03:25. What are our options for dealing with coronary calcification?
05:40. Fifteen percent of cases require calcium modification, but the use of atherectomy is low. What are the reasons for that?
08:53. What should operators be aware of when using IVL technology and what was the incidence of complications reported in the Disrupt III trial?
12:35. For people thinking about bringing IVL technology into their labs, what should they be aware of besides the clinical data?
15:30. How will this affect use of current calcium modification therapies?
16:21. How will it affect rates of in-stent restenosis?

Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Acknowledgment of Commercial Support

This activity is supported by an unrestricted educational grant from Shockwave. No in-kind commercial support was received.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered